The negotiated prices are a result of a program passed by Congress in 2022 as part of the Inflation Reduction Act (IRA). The ...
Sonrotoclax has received FDA priority review for relapsed or refractory mantle cell lymphoma, indicating potential substantial treatment improvement. The BGB-11417-201 study demonstrated significant ...
President Donald Trump’s administration announced that Medicare will pay reduced prices for 15 prescription drugs, including ...
A phase 2 study reveals high efficacy and manageable safety of venetoclax plus obinutuzumab for untreated CLL/SLL in Japanese ...
A short film that premiered earlier this month tracks the journeys of three people who discovered a renewed commitment to ...
FITBOOK magazine on MSN
Signs That May Indicate Blood Cancer
The term leukemia, commonly known as blood cancer, is already familiar to most people. No wonder–in Germany, around 12,200 ...
Dr. Charles M. Rudin highlighted new small cell lung cancer therapies, including T cell engagers, antibody-drug conjugates, ...
Record-setting presence at ASH reflects widespread recognition of clonoSEQ as a standard-of-care tool for personalizing ...
Investigators from Hackensack Meridian John Theurer Cancer Center (JTCC)—a leading research partner of the NCI-designated ...
Nurix Therapeutics is trimming its workforce not long after launching a pivotal phase 2 trial for its lead cancer asset. | ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback